Feb 1 (Reuters) - D.Western Therapeutics Institute Inc
4576.T :
* Says the co to buy ophthalmic surgical adjuvant business,
which includes ingredient of Brilliant Blue G-250, from Healios
KK 4593.T
* Says the acquisition price is set at 1.3 billion yen
* Says effective date on April 30
Source text in Japanese:https://goo.gl/2zf5HO;
https://goo.gl/CmNCme
Further company coverage: 4576.T 4593.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 10 62674724;
Reuters Messaging: jun.cao.reuters.com@reuters.net))